Published in Arch Neurol on May 01, 1975
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation (2008) 1.41
Subacute leukoencephalopathy complicating acute lymphoblastic leukemia. West J Med (1987) 1.40
Neuropathologic observations in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol (1985) 1.08
CNS toxoplasmosis in acquired immune deficiency syndrome: a clinical-pathological-radiological review of 12 cases. J Neurol Neurosurg Psychiatry (1986) 0.93
A case of acute polyradiculoneuritis and acquired toxoplasmosis. J Neurol Neurosurg Psychiatry (1984) 0.80
Acquired toxoplasma encephalitis. Arch Dis Child (1986) 0.77
Spinal Cord Lesions in Congenital Toxoplasmosis Demonstrated with Neuroimaging, Including Their Successful Treatment in an Adult. J Neuroparasitology (2012) 0.75
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep (2016) 0.75
Acute acquired toxoplasmosis causing neuroptico-meningoencephalitis in an immunocompetent boy. J Neurol Neurosurg Psychiatry (1985) 0.75
Central Nervous System Toxoplasmosis in Relapsed Hodgkin's Lymphoma: A Case Report. Iran J Cancer Prev (2016) 0.75
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer (1997) 3.58
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med (1988) 2.65
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med (1987) 2.05
Facial neuromuscular retraining for oral synkinesis. Plast Reconstr Surg (1997) 1.97
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
The MRI appearance of cavernous malformations (angiomas). J Neurosurg (1987) 1.93
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Autoregulation of blood flow. Circ Res (1986) 1.84
Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol (2007) 1.83
H reflex studies in cerebral palsy patients undergoing partial dorsal rhizotomy. Muscle Nerve (1994) 1.83
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control (1995) 1.83
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology (2001) 1.76
Acalvaria: a unique congenital anomaly. Am J Med Genet (1993) 1.75
The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol (1997) 1.69
Intraneural perineurioma of the common peroneal nerve. Case report and review of the literature. J Neurosurg (2001) 1.68
Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol (2001) 1.66
Changes in facial movement after maxillary osteotomies. J Oral Maxillofac Surg (1997) 1.66
Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol (1970) 1.65
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol (1998) 1.61
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol (1983) 1.60
Variable results after rituximab in neuromyelitis optica. J Neurol Sci (2012) 1.58
Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect Immun (1979) 1.58
The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis (1986) 1.54
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Herpes simplex virus infection of nervous tissue in animals and man. Prog Med Virol (1975) 1.52
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Choroid plexus carcinoma in siblings: a study by light and electron microscopy with Ki-67 immunocytochemistry. J Neuropathol Exp Neurol (1989) 1.52
Sensory perineuritis. Arch Neurol (1972) 1.51
Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2. J Biol Chem (1985) 1.49
Erythrocyte velocity measurement in microvessels by a two-slit photometric method. J Appl Physiol (1967) 1.49
The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology (2009) 1.49
Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability. Neurology (1995) 1.48
False aneurysm associated with rupture of an arteriovenous malformation--implications for treatment: case report. Neurosurgery (1993) 1.47
Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci U S A (1998) 1.46
Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology (1980) 1.44
Immunochemical identification of rubella virus hemagglutinin. Virology (1983) 1.44
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest (1989) 1.42
Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42
Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis (1995) 1.41
Red blood cell mass and plasma volume changes in manned space flight. JAMA (1967) 1.41
Subacute leukoencephalopathy complicating acute lymphoblastic leukemia. West J Med (1987) 1.40
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
Norwalk virus antigen and antibody response in an adult volunteer study. J Clin Microbiol (1987) 1.39
3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler (2008) 1.39
Cross-facial nerve grafting for facial reanimation: effect on normal hemiface motion. J Reconstr Microsurg (1996) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
Evaluation and treatment of the plastic surgical patient having a potential to bleed. Plast Reconstr Surg (1995) 1.38
Sequence determination of the mumps virus HN gene. Virology (1988) 1.38
Pathogenesis of diabetic neuropathy. Ann Neurol (1986) 1.36
Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis. Ann Neurol (2001) 1.35
Regional ventilation and perfusion after lung transplantation in patients with emphysema. N Engl J Med (1970) 1.35
Pathophysiology of multiple sclerosis and the place of teriflunomide. Acta Neurol Scand (2010) 1.34
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry (1997) 1.34
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
An acute syndrome of ocular oscillations and truncal myoclonus. Brain (1968) 1.31
Regulation of blood flow in single capillaries. Am J Physiol (1967) 1.31
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
Primary culture of capillary endothelium from rat brain. In Vitro (1981) 1.30
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
Tubular aggregates in endoplasmic reticulum in herpes-simplex encephalitis. N Engl J Med (1971) 1.29
Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery (1991) 1.28
Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology (1983) 1.28
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Rheological effects of red blood cell aggregation in the venous network: a review of recent studies. Biorheology (2001) 1.28
Chronic hypoventilation of central origin. A case with encephalitis lethargica and Parkinson's syndrome. Am Rev Respir Dis (1967) 1.28
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol (1995) 1.28
Microvascular and tissue oxygen distribution. Cardiovasc Res (1996) 1.27
Suppression of insulin release by fish-insulin-induced hypoglycaemia: with reference to the diagnosis of insulinomas. Lancet (1973) 1.27
Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology (1981) 1.27
Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies. Virology (1985) 1.26
Neuronal and oligodendroglial infection by the WW strain of Theiler's virus. Lab Invest (1979) 1.25
Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother (2001) 1.24
A dual approach for minimizing false lesion classifications on magnetic resonance images. Magn Reson Med (1997) 1.24
Tubular aggregates in endoplasmic reticulum: evidence against their viral nature. J Ultrastruct Res (1972) 1.23
Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol (1985) 1.23
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23